Sanara MedTech (SMTI) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Sanara MedTech (SMTI) over the last 9 years, with Q3 2025 value amounting to -$3.4.
- Sanara MedTech's EPS (Weighted Average and Diluted) fell 90000.0% to -$3.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.22, marking a year-over-year decrease of 32626.26%. This contributed to the annual value of -$1.16 for FY2024, which is 11586.63% down from last year.
- According to the latest figures from Q3 2025, Sanara MedTech's EPS (Weighted Average and Diluted) is -$3.4, which was down 90000.0% from -$0.23 recorded in Q2 2025.
- In the past 5 years, Sanara MedTech's EPS (Weighted Average and Diluted) registered a high of $0.09 during Q2 2022, and its lowest value of -$3.4 during Q3 2025.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$0.5, with a median of -$0.22 in 2023.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 9397.99% in 2023, then tumbled by 250382.91% in 2024.
- Quarter analysis of 4 years shows Sanara MedTech's EPS (Weighted Average and Diluted) stood at -$0.53 in 2022, then surged by 93.98% to -$0.03 in 2023, then tumbled by 2503.83% to -$0.83 in 2024, then tumbled by 311.91% to -$3.4 in 2025.
- Its EPS (Weighted Average and Diluted) was -$3.4 in Q3 2025, compared to -$0.23 in Q2 2025 and -$0.41 in Q1 2025.